New: NCI-funded clinical trial search
Mednet Logo
CommunityEndocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

How do you decide between adding oral orforglipron or starting prandial insulin in a patient with type 2 diabetes above goal on basal insulin?

1
1 Answers

Mednet MemberInvited Expert
Endocrinology · Texas Diabetes And Endocrinology Pa

This is a timely question in that it is clinically relevant, and in June 2026, the ACHIEVE-5 trial was published online in JAMA, which studied adding orforglipron to basal insulin.If the patient is judged to be significantly insulinopenic--thin, low dose of basal insulin requirement, and high postpr...

What is the evidence, if any, for the use of low dose naltrexone in the treatment of autoimmune thyroiditis?

2 Answers

Mednet MemberInvited Expert
Endocrinology · Oregon Health Sciences University Portland State University School Of Public Hea

I do not prescribe naltrexone for thyroid disease because I have not found data to support its use. In theory, low dose naltrexone (LDN) could decrease inflammation and thus potentially block development of overt hypothyroidism in TPO positive patients. But, at this time, it is anecdotal, with no ha...

How long do you typically treat patients with phentermine for weight loss and what clinical markers do you follow?

1
2 Answers

Mednet MemberInvited Expert
Endocrinology · Tufts Medical Center Physicians Organization

Phentermine has been available since 1959 and remains an affordable and effective medication option added to a full lifestyle-based weight management plan. In people who are generally healthy and without contraindications to the medication, I have had patients used in at least intermittently for sev...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

What are the main differences between TRYNGOLZA and Redemplo?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Medical University of South Carolina College of Medicine

TRYNGOLZA (olesarsen) and Redemplo (plozasiran) both work to reduce apoC-III production, a known inhibitor of LPL activity, thus leading to significant triglyceride lowering. Olezarsen is an antisense oligonucleotide, and plozasirin is an siRNA. Both lower triglycerides by 40-60% and both are FDA-ap...

Do you use FRAX score or BMD scores to determine whether patients with primary hyperparathyroidism would benefit from parathyroidectomy to reduce fracture risk?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Stanford Health Care

I use FRAX for all patients. Basing a diagnosis of osteoporosis simply by a patient having one T-score >2.5 SD below the mean of young normal persons diagnoses only 1/3 of women older than 50 who experience a fracture of the spine, hip or wrist. FRAX uses femoral neck BMD values, as well as other re...

Do you get DEXA scans routinely before starting ADT for prostate cancer or endocrine therapy for breast cancer?

7
5 Answers

Mednet Member
Medical Oncology · Malcolm Randall VAMC

When initiating long-term ADT, I order a DEXA scan, check vitamin D level, ensure adequate dietary calcium intake, and discuss weight-bearing exercise/refer to PT when appropriate. I also continue check DEXAs every 2 years unless they otherwise meet criteria for a bone-modifying agent (mCRPC with bo...

For patients on weekly insulin (AWIQLI), do you recommend reducing their dose prior to major surgery?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Texas Diabetes And Endocrinology Pa

Thanks for the question. AWIQLI (insulin icodec) has a half-life of 8 days. Insulin efsitora, which has a half-life of 19 days, was just approved. Both are approved only for people with type 2 diabetes. These weekly basal insulins have the potential to improve compliance and reduce the burden of inj...

What is your approach to the use of GLP-1 agonists in older adults with diabetes with or at risk of sarcopenia?

2
5 Answers

Mednet Member
Geriatric Medicine · University of California, San Francisco

This is an important question to keep an eye on, given the broadening use and effectiveness of GLP-1 agonists for various conditions, especially diabetes, and for weight loss. Unfortunately, as is so often the case, major clinical trials in this area do not reflect the heterogeneity of older adults ...

Does cinacalcet reduce hypercalciuria in primary hyperparathyroidism?

1 Answers

Mednet MemberInvited Expert
Endocrinology · U Conn

Thank you for asking, and please remember that cinacalcet is an excellent temporary treatment option because it does not protect bone. Cinacalcet is usually prescribed when parathyroidectomy is absolutely not an option (rare, given the surgical talent) or must be delayed. There are patients with rec...

What is the correct dose of Lugol's iodine solution and duration of therapy for preparing a thyrotoxic patient for surgery and minimizing the risk of thyroid storm?

1 Answers

Mednet MemberInvited Expert
Endocrinology · BMCWorking Well Occupational Health Clinic

Potassium iodide (KI) can be given 3 times per day in a full glass of water or juice (bitter) for 10 days before Graves' hyperthyroidism surgery as follows: Lugol's solution (8 mg iodide/drop): 5-7 drops Saturated solution of potassium iodide (SSKI) (50 mg iodide/drop): 1-2 drops Minor calculated ...